BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400
1127 results:

  • 1. Early comparison robotic bronchoscopy versus electromagnetic navigational bronchoscopy for biopsy of pulmonary nodules in a thoracic surgery practice.
    Trimble EJ; Stewart K; Reinersman JM
    J Robot Surg; 2024 Apr; 18(1):149. PubMed ID: 38564059
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Complex Genomic Rearrangement Patterns in Malignant Pleural Mesothelioma due to Environmental Asbestos Exposure.
    Tuncel T; Ak G; Güneş HV; Metintaş M
    J Environ Pathol Toxicol Oncol; 2024; 43(2):13-27. PubMed ID: 38505910
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cisplatin-resistance induces lung squamous carcinoma cell growth by nicotine-mediated α7nAchR/HDAC1/Cyclin D1/pRb cell cycle activation.
    Rao L; Guo D; Wu JP
    Cell Biochem Funct; 2024 Mar; 42(2):e3990. PubMed ID: 38504444
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evolutionary trajectories of small cell lung cancer under therapy.
    George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
    Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. P53 and Rb Aberrations in Small Cell lung cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation.
    Papavassiliou KA; Sofianidi AA; Gogou VA; Anagnostopoulos N; Papavassiliou AG
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473726
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action.
    Pandini C; Pagani G; Tassinari M; Vitale E; Bezzecchi E; Saadeldin MK; Doldi V; Giannuzzi G; Mantovani R; Chiara M; Ciarrocchi A; Gandellini P
    Cell Death Dis; 2024 Mar; 15(3):206. PubMed ID: 38467619
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression.
    Cai H; Zhang B; Ahrenfeldt J; Joseph JV; Riedel M; Gao Z; Thomsen SK; Christensen DS; Bak RO; Hager H; Vendelbo MH; Gao X; Birkbak N; Thomsen MK
    Nat Commun; 2024 Mar; 15(1):2088. PubMed ID: 38453924
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Intranasal delivery of herbal medicine for disease treatment: A systematic review.
    Tran KN; Kwon JH; Kim MK; Nguyen NPK; Yang IJ
    Phytomedicine; 2024 May; 127():155484. PubMed ID: 38442431
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell lung cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation.
    Zhao R; Li J; Guo L; Xiang C; Chen S; Zhao J; Shao J; Zhu L; Ye M; Qin G; Chu T; Han Y
    Target Oncol; 2024 Mar; 19(2):277-288. PubMed ID: 38416376
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Next-Generation Sequencing in lung cancers-A Single-Center Experience in Taiwan.
    Lai WA; Huang YS; Chang KC; Yang SF; Yang CJ; Liu YW; Chen HD
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399524
    [No Abstract]    [Full Text] [Related]  

  • 11. Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype.
    Ma W; Zhou T; Song M; Liu J; Chen G; Zhan J; Ji L; Luo F; Gao X; Li P; Xia X; Huang Y; Zhang L
    J Transl Med; 2024 Feb; 22(1):189. PubMed ID: 38383412
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CDK4/6 inhibitors in lung cancer: current practice and future directions.
    Lv S; Yang J; Lin J; Huang X; Zhao H; Zhao C; Yang L
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38355149
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effect of CDK4/6 Inhibitors on Tumor Immune Microenvironment.
    Liu J; Cheng M; Xu J; Liang Y; Yin B; Liang J
    Immunol Invest; 2024 Apr; 53(3):437-449. PubMed ID: 38314676
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Using Pharmacokinetic-Pharmacodynamic Modeling to Study the Main Active Substances of the Anticancer Effect in Mice from
    Liu L; Lyu J; Yang L; Gao Y; Zhao B
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257247
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice.
    Daenekas B; Pérez E; Boniolo F; Stefan S; Benfatto S; Sill M; Sturm D; Jones DTW; Capper D; Zapatka M; Hovestadt V
    Bioinformatics; 2024 Feb; 40(2):. PubMed ID: 38244574
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
    Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
    Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of rb1 in non-small cell lung cancer.
    Ding X; Shi MX; Liu D; Cao JX; Zhang KX; Zhang RD; Zhang LP; Ai KX; Su B; Zhang J
    Cell Commun Signal; 2024 Jan; 22(1):45. PubMed ID: 38233864
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetically-engineered mouse models of small cell lung cancer: the next generation.
    Oser MG; MacPherson D; Oliver TG; Sage J; Park KS
    Oncogene; 2024 Feb; 43(7):457-469. PubMed ID: 38191672
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comprehensive Genomic Analysis of Patients With Non-Small-Cell lung cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan.
    Wang HY; Ho CC; Lin YT; Liao WY; Chen CY; Shih JY; Yu CJ
    JCO Precis Oncol; 2024 Jan; 8():e2300314. PubMed ID: 38190582
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
    Liu Q; Zhang J; Guo C; Wang M; Wang C; Yan Y; Sun L; Wang D; Zhang L; Yu H; Hou L; Wu C; Zhu Y; Jiang G; Zhu H; Zhou Y; Fang S; Zhang T; Hu L; Li J; Liu Y; Zhang H; Zhang B; Ding L; Robles AI; Rodriguez H; Gao D; Ji H; Zhou H; Zhang P
    Cell; 2024 Jan; 187(1):184-203.e28. PubMed ID: 38181741
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 57.